Epithelial borderline ovarian tumor: Diagnosis and treatment strategy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Epithelial borderline ovarian tumors (BOT) are distinctive from benign tumors and carcinoma. They occur in younger women more often than carcinoma, and there is some difficulty making correct diagnosis of BOT. Two subtypes of BOT, serous and mucinous borderline tumor have different characteristics and very different clinical behavior. Serous borderline tumor (SBT) with micropapillary pattern shows more incidence of extra ovarian disease and often coexists with invasive implant. SBT with micropapillary pattern in advanced stage has showed a worse prognosis than typical SBT. Huge mucinous borderline tumors have histologic heterogeneity, and the accuracy of frozen section diagnosis is relatively low. Extensive sampling is required to reach a correct pathological diagnosis. Mucinous adenoma (intestinal type) also runs the risk of recurrence after cystectomy, or intraoperative rupture of cyst. Laparoscopic procedure for BOT has not increased the risk of recurrence. Fertility preserving procedures are generally accepted, except in advanced stage SBT with invasive implants. Only cystectomy shows a significant risk of recurrence. Re-staging surgery and full staging surgery is not necessary for all BOT. We should not attempt to treat them uniformly, by the single diagnosis of “borderline tumor”. It depends on histologic type. Close communication with the pathologist is necessary to gain more detail and ask more pathological samples in order to make the optimal treatment strategy for each individual patients.
Abstract
Epithelial borderline ovarian tumors (BOT) are distinctive from benign tumors and carcinoma. They occur in younger women more often than carcinoma, and there is some difficulty making correct diagnosis of BOT. Two subtypes of BOT, serous and mucinous borderline tumor have different characteristics and very different clinical behavior. Serous borderline tumor (SBT) with micropapillary pattern shows more incidence of extra ovarian disease and often coexists with invasive implant. SBT with micropapillary pattern in advanced stage has showed a worse prognosis than typical SBT. Huge mucinous borderline tumors have histologic heterogeneity, and the accuracy of frozen section diagnosis is relatively low. Extensive sampling is required to reach a correct pathological diagnosis. Mucinous adenoma (intestinal type) also runs the risk of recurrence after cystectomy, or intraoperative rupture of cyst. Laparoscopic procedure for BOT has not increased the risk of recurrence. Fertility preserving procedures are generally accepted, except in advanced stage SBT with invasive implants. Only cystectomy shows a significant risk of recurrence. Re-staging surgery and full staging surgery is not necessary for all BOT. We should not attempt to treat them uniformly, by the single diagnosis of “borderline tumor”. It depends on histologic type. Close communication with the pathologist is necessary to gain more detail and ask more pathological samples in order to make the optimal treatment strategy for each individual patients.
참고문헌 (15)
- Taylor HC., "Malignant and semimalignant tumors of the ovary", Surg Gynecol Obstet, 48, pp.204~230 (1929)
- 송태종, "Histologic distribution of borderline ovarian tumors worldwide: a systematic review", Journal of Gynecologic Oncology, 24(1), pp.44~51 (2013), 대한부인종양학회
- Bell DA., "Serous borderline(low malignant potential, atypical proliferative)ovarian tumors : workshop perspectives", Hum Pathol, 35, pp.934~948 (2004)
- Fadare O., "A comparative analysis of lymphatic vessel density in ovarian serous tumors of low malignantpotential(borderline tumors)with and without lymph node involvement", Int J Gynecol Pathol, 27, pp.483~490 (2008)
- Prat J., "Pathology of the ovary" (2004), Saunders
- Seidman JD., "Ovarian serous borderline tumors : a critical review of the literature with emphasis on prognostic indicators", Hum Pathol, 31, pp.539~557 (2000)
- Hart WR., "Mucinous tumors of the ovary : a review", Int J Gynecol Pathol, 24, pp.4~25 (2005)
- Shappell HW., "Diagnostic criteria and behavior of ovarian seromucinous(endocervical-type mucinous and mixed cell-type)tumors : atypical proliferative(borderline)tumors, intraepithelial, microinvasive, and invasive carcinomas", Am J Surg Pathol, 26, pp.1529~1541 (2002)
- Brun JL., "Factors influencing the use and accuracy of frozen section diagnosis of epithelial ovarian tumors", Am J Obstet Gynecol, 199, pp.244.e1~244.e7 (2008)
- Storms AA., "Mucinous tumors of the ovary : diagnostic challenges at frozen section and clinical implications", Gynecol Oncol, 125, pp.75~79 (2012)
- Koskas M., "Prognostic factors of a large retrospective series of mucinous borderline tumors of the ovary(excluding peritoneal pseudomyxoma)", Ann Surg Oncol, 18, pp.40~48 (2011)
- Chiesa AG., "Ovarian intestinal type mucinous borderline tumors : are we ready for a nomenclature change?", Int J Gynecol Pathol, 29, pp.108~112 (2010)
- Ben-Ami I., "Does intraoperative spillage of benign ovarian mucinous cystadenoma increase its recurrence rate?", Am J Obstet Gynecol, 202, pp.142.e1~142.e5 (2010)
- Morice P., "Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence", Lancet Oncol, 13, pp.e103~e115 (2012)
- Fauvet R., "Restaging surgery for women with borderline ovarian tumors : results of a French multicenter study", Cancer, 100, pp.1145~1151 (2004)